Page last updated: 2024-08-26

cilastatin and Renal Insufficiency

cilastatin has been researched along with Renal Insufficiency in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Bhagunde, P; Boundy, K; Butterton, JR; Colon-Gonzalez, F; Garrett, G; Jumes, P; Lala, M; Lasseter, K; Liu, Y; Marbury, T; Rhee, EG; Rizk, ML; Wu, J; Xu, SS	1
Abe, Y; Aoki, N; Arita, M; Goto, S; Hayashi, M; Hokari, S; Hosojima, M; Ichikawa, K; Kabasawa, H; Kikuchi, T; Kondo, R; Koya, T; Kuwahara, S; Nozaki, K; Ohshima, Y; Ohtsubo, A; Saito, A; Sato, M; Shoji, S; Suzuki, R; Takahashi, M; Watanabe, S	1
Ebira, H; Ikeda, Y; Kihara, M; Masumori, S; Shibata, K; Shionoiri, H; Shiratori, K; Takagi, N; Ueda, S; Umemura, S	1
Craig, WA	1

Reviews

1 review(s) available for cilastatin and Renal Insufficiency

Article	Year
The pharmacology of meropenem, a new carbapenem antibiotic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24 Suppl 2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Child; Child, Preschool; Cilastatin; Clinical Trials as Topic; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infant; Infant, Newborn; Kidney; Male; Meropenem; Microbial Sensitivity Tests; Molecular Structure; Renal Insufficiency; Thienamycins	1997

Article

Year

The pharmacology of meropenem, a new carbapenem antibiotic.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24 Suppl 2

Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Child; Child, Preschool; Cilastatin; Clinical Trials as Topic; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infant; Infant, Newborn; Kidney; Male; Meropenem; Microbial Sensitivity Tests; Molecular Structure; Renal Insufficiency; Thienamycins

1997

Trials

1 trial(s) available for cilastatin and Renal Insufficiency

Article	Year
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin. British journal of clinical pharmacology, 2020, Volume: 86, Issue:5 Topics: Adult; Aged; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cilastatin; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Organic Anion Transporters; Renal Insufficiency; Young Adult	2020

Article

Year

Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin.

British journal of clinical pharmacology, 2020, Volume: 86, Issue:5

Topics: Adult; Aged; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cilastatin; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Organic Anion Transporters; Renal Insufficiency; Young Adult

2020

Other Studies

2 other study(ies) available for cilastatin and Renal Insufficiency

Article	Year
Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity. Scientific reports, 2021, 01-12, Volume: 11, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cilastatin; Cisplatin; Colonic Neoplasms; Female; Glomerular Filtration Rate; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Inbred NOD; Mice, SCID; Renal Insufficiency; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2021
Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients. Clinical nephrology, 1994, Volume: 42, Issue:3 Topics: Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Half-Life; Humans; Imipenem; Infusions, Intravenous; Male; Renal Dialysis; Renal Insufficiency	1994

Article

Year

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity.

Scientific reports, 2021, 01-12, Volume: 11, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cilastatin; Cisplatin; Colonic Neoplasms; Female; Glomerular Filtration Rate; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Inbred NOD; Mice, SCID; Renal Insufficiency; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021

Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.

Clinical nephrology, 1994, Volume: 42, Issue:3

Topics: Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Half-Life; Humans; Imipenem; Infusions, Intravenous; Male; Renal Dialysis; Renal Insufficiency

1994